GlassScriptPhysician profile
Melissa Jarvis
NPI 1831976620
$1,351.95
in general payments reported to CMS, 2019-2025
14 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $205 · 2024: $874 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $267.87 | 2024 | |
| Abbvie INC. | $267.19 | 2024-2025 | |
| Medtronic, INC. | $210.70 | 2023-2024 | Interstim |
| Axonics, INC. | $189.99 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $182.43 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $51.20 | 2024-2025 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $36.37 | 2025 | Ams 700, Axonics |
| Avation Medical, INC. | $26.29 | 2024 | Vivally |
| Bayer Healthcare Pharmaceuticals INC. | $25.94 | 2025 | |
| Progenics Pharmaceuticals, INC. | $24.55 | 2025 | |
| Merck Sharp & Dohme LLC | $23.56 | 2025 | Keytruda |
| Palette Life Sciences, INC. | $16.29 | 2023 | |
| Laborie Medical Technologies Corp. | $15.71 | 2025 | |
| Endo Pharmaceuticals INC. | $13.86 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Jarvis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.